The government’s top vaccine official working under Health Secretary Robert F. Kennedy Jr. recently restricted the approval ...

British drugmaker GSK said on Monday it had submitted an application to the U.S. Food and Drug Administration to extend the ...

A new study of more than 1.2 million people found no link between aluminum in childhood vaccines and long-term health ...

GSK announces US FDA accepts application to review expanded use of RSV vaccine, Arexvy for adults 18-49 at increased risk: London, UK Wednesday, July 16, 2025, 14:00 Hrs [IST] GSK ...

The US Food and Drug Administration’s top vaccine official overrode agency experts in May to recommend against the broad use ...

Arexvy is currently approved to prevent lower respiratory tract disease (LRTD) caused by RSV in individuals aged 60 years and older, and those 50 to 59 years of age who are at increased risk for LRTD ...

The FDA action comes weeks after US Health Secretary Robert F. Kennedy Jr said the government would no longer recommend the COVID vaccine for healthy children or pregnant people.

The United States Senate’s Permanent Subcommittee on Investigations was scheduled to hold its second hearing on vaccines on Tuesday. Committee member Richard Blumenthal (D-CT) expressed skepticism ...

A study reveals that rising vaccine coverage in children is linked to reduced antibiotic prescriptions, suggesting a shift in ...